Navigation Links
deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
Date:3/14/2008

REYKJAVIK, Iceland, March 14 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced that it will host a live webcast of deCODE CEO Kari Stefansson's presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference.

The presentation will be delivered at 1:30 PM ET / 5:30 GMT on Wednesday, March 19 at the Loews Miami Beach Hotel in Florida. The webcast can be accessed through the Investors page on deCODE's website, http://www.decode.com, and those interested in listening should log on a few minutes in advance in order to download any software or complete any sign-in that may be required. The webcast will be archived for at least one week.

About deCODE

deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs and diagnostics for common diseases. deCODE is a global leader in gene discovery -- our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the basic biology of disease. deCODE is also leveraging its expertise in human genetics and integrated drug discovery and development capabilities to offer innovative products and services in personal genome analysis, DNA-based diagnostics, bioinformatics, genotyping, structural biology, drug discovery and clinical development. deCODE is delivering on the promise of the new genetics(SM). Visit us on the web at http://www.decode.com; on our diagnostics website at http://www.decodediagnost
'/>"/>

SOURCE deCODE genetics
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
2. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results
3. deCODE genetics Announces Third Quarter 2007 Financial Results
4. deCODE Launches deCODEme(TM)
5. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
6. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
7. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
8. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
9. deCODE Genetics Announces Full-year 2007 Financial Results
10. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
11. Response Genetics Reports Second Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...9 /PRNewswire-Asia/ -- The pharma and biotech sect...e companies are facing significant,pressure to cha...costs, calls for,lower prices and a greater regula...nancial crisis have made the work of creating new ...es are being forced to globalize their R&D,ope...
(Date:11/9/2009)... Product release is a research industry first, all...ities and research safety study data to be managed... Cedar Knolls, NJ (PRWEB) November 9, 2009 -...as unveiled Pristima™ VM, an integrated ente...hat track the use and care of veterinary research ...
(Date:11/7/2009)...ov. 7, Research projects in the ar...ks this evening, as Tim Kunisky of Livingston, NJ ... of Audubon, PA received the highest honors at the...n in Math, Science & Technology, the nation,s ...http://www.newscom.com/cgi-bin/prnh/20070904/SIEME...
(Date:11/6/2009)... 6 Myriant Technologies LLC ("Myri...ufacturer of renewable bio-chemicals, Uhde Corpor...ider Uhde GmbH, one of the world,s leading enginee...liance for the engineering, procurement & cons... plants based on renewable feedstocks. The execut...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in Shanghai 2Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3
... Data Highlight The Efficacy, Safety and Significa...ymptoms With Zebinix(TM) (Eslicarbazepine,Acetate)...s presented today at the,American Epilepsy Society...M)(1) (eslicarbazepine acetate), a novel once-dail...frequency of partial seizures and has the,potentia...
...etics,(Nasdaq: DCGN ) today announced the discov...rom deCODE and major European and US academic inst... genome (SNP) that is associated with,increased fa...T2D). deCODE,will employ its CLIA-registered genot...swiftly integrate the finding into its deCODEme(TM...
...group in Trinity,Biotech plc (Nasdaq: TRIB ), an...tic products, has reconfigured the slate of replac...special meeting of the company,s shareholders,that..., speaking on behalf of,the group, announced that ...daVinci Capital Group, would replace Steven Mock o...
Other Biology Technology:Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 2Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 3Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 4Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 5Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 6Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM) 7deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Service 2deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Service 3deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Service 4Investor Group Reconfigures Proposed Slate of Replacement Directors for Trinity Biotech 2
(Date:11/6/2009)... To celebrate the 150th anniversary this month of ...merican Institute of Biological Sciences (AIBS) is... about Charles Darwin and his historic insights in...ian of the University of California, Berkeley, and...dian,s article, "Ten Myths About Charles Darwin," ...
(Date:11/6/2009)... PHILADELPHIA (November 06, 2009) The Monell Cent...o-hosts of the Beijing International Meeting on Ta...laboration with the CAS, the meeting will be the f...e held in China. , Alan Leshner, Chief Executive... of Science and Executive Publisher of Science mag...
(Date:11/5/2009)... Kent State University has been awarded a training... Science Foundation under its Integrative Graduati.... This is the first IGERT grant to be awarded to K...erican Recovery and Reinvestment Act of 2009, runs...t that focuses on environment aquatic resource sen...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Hospira Names Daphne E Jones Chief Information Officer 5611 1Hospira Names Daphne E Jones Chief Information Officer 5611 2Verizon Health Care Experts to Address 2009 Connected Health Symposium in Boston on Oct 21 59823 1Verizon Health Care Experts to Address 2009 Connected Health Symposium in Boston on Oct 21 59823 2Inverness Medical Innovations Schedules Conference Call for 10 3A00 a m ET October 27 2009 to Discuss Third Quarter 2009 Results 14544 1Inverness Medical Innovations Schedules Conference Call for 10 3A00 a m ET October 27 2009 to Discuss Third Quarter 2009 Results 14544 2
...to predict the impact of climate change on the den...tralia information that could help limit its spre...ew issue of the British Ecological Society,s journ...ionary change could act together to accelerate and... in the form of storing water to cope with climate...
...University associate research scientist Melha Mell...eading a USDA funded project to develop a vaccine ...hogenic E. coli (APEC). , APEC is part of a la...inal pathogenic E. coli (ExPEC). They cause a nu...ases in human, animals, and birds. There is also c...
...ed Wegener Institute for Polar and Marine Research...ing Polarstern expedition LOHAFEX". Independent sc...inistry of Education and Research and the Federal ...and Nuclear Safety concluded that the iron fertili...onmental standards nor the international law in fo...
Other Biology News:Hoarding rainwater could 'dramatically' expand range of dengue-fever mosquito 2New insights into a leading poultry disease and its risks to human health 2New insights into a leading poultry disease and its risks to human health 3New insights into a leading poultry disease and its risks to human health 4Polarstern expedition 'LOHAFEX' can be conducted 2Polarstern expedition 'LOHAFEX' can be conducted 3
Mouse/Rat Anti-Canine CD3 / CD4 Dual Colour Reagent Antibody, FITC / R-Phycoerythrin Conjugated from AbD Serotec
4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) *FluoroPure™ grade* from Molecular Probes (Invitrogen)
Essential Techniques: Gel Electrophoresis: Proteins from Promega
Colloids and Interfaces with Surfactants and Polymers an Introduction. Jim Goodwin. Wiley (2004); 296 pages soft cover from Invitrogen
Biology Products: